| Molecular formula | C38H68N6O8 |
|---|
| Molecular weight | 737 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 10212452 |
|---|
Palmitoyl hexapeptide-12 is a compound of interest in research settings, and many people search for it without realizing it carries no approved medical use. This article lays out what is currently known about its chemical identity and its presence in clinical trial registries.
Regulatory status
Palmitoyl hexapeptide-12 is classified as an unapproved research compound. It has no FDA-approved label, no approved indications, and no approved brand name.
What palmitoyl hexapeptide-12 is
Palmitoyl hexapeptide-12 is a synthetic peptide with the molecular formula C38H68N6O8 and a molecular weight of approximately 737. It is catalogued in PubChem under CID 10212452. No FDA label exists for this compound, so no mechanism of action or drug class can be sourced from regulatory labeling.
Trial footprint
Registry data reviewed for this compound show zero registered clinical trials. There is no trial sample to report and no phase or status information available from the sources reviewed.
FAQ
No. Palmitoyl hexapeptide-12 has no FDA-approved label or approved indication. It is classified as an unapproved research compound.
It is a synthetic peptide with the molecular formula C38H68N6O8 and a molecular weight of about 737. Its structure is catalogued in PubChem under CID 10212452.
Registry data reviewed for this compound show zero registered clinical trials at this time. This means there is no clinical trial evidence currently available to assess.
No side effect or adverse event report data was available for this compound in the sources reviewed. This is different from confirming that it has no side effects.
It means the compound has not gone through the regulatory review needed to be legally marketed as a drug for any use. It has no FDA-approved label, indication, or brand name.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 10212452 ClinicalTrials.gov registry search
Updated 2026-08-10